REFERENCES
- Arikan S, Rex JH. 122 — Antifungal Agents. In: Murray PR, Baron GJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of Clinical Microbiology, volume 2. Washington DC: ASM Press, 2003.
- Kanbe T, Arishima T, Horii T, Kikuchi A. Improvements of PCR-based identification targeting the dna topoisomerase II gene to determine major species of the opportunistic fungi Candida and Aspergillus fumigatus. Microbiol Immunol 2003; 47: 631–638.
- NCCLS. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast—Second Edition: Approved Stan-dard M27-A2 2002. Wayne, PA, USA: NCCLS.
- Pfaller MA, Messer SA, Bolmström, Odds FC, Rex JH. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol 1996; 34: 1691–1693.
- Wanger A, Mills K, Nelson PW, Rex JH. Comparison of Etest and National Committee for Clinical Laboratory Standards Broth Macrodilution Method for Antifungal Susceptibility Testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob Agents Chemother 1995; 39: 2520–2522.
- Silva MRR, Costa MR, Miranda ATB, Fernandes OFL, Costa CR, Paula CR. Evaluation of Etest and macrodilution broth method for antifungal susceptibility testing of Candida sp strains isolated from oral cavities of aids patients. Rev Inst Med Trop S Paulo 2002; 44: 121–135.
- Alexander BD, Byrne TC, Smith KL, Hanson KE, Anstrom KJ, Perfect JR et al. Comparative evaluation of Etest and Sensi-titre YeastOne Panels against the Clinical and Laboratory Stan-dards Institute M27-A2 Reference Broth Microdilution Method for Testing Candida susceptibility to seven antifungal agents. J Clin Microbiol 2007; 45: 698–706.
- Diekema DJ, Messer SA, Hollis RJ, Boyken LB, Tandolkar S, Kroeger J et al. Evaluation of Etest and Disk Diffusion Meth-ods Compared with Broth Microdilution Antifungal Susceptibility Testing of Clinical Isolates of Candida spp. against posacona-zole. J Clin Microbiol 2007; 45: 1974–1977.
- Crocco El, Souza VM, Mimica LMJ, Ruiz LRB, Muramatu LH, Garzia C et al. Identificacão de espécies de Candida e sus-ceptibilidade antikingica in vitro: estudo de 100 pacientes com candidiases superficiais. An Bras Derm 2004; 79: 689–697.
- CLSI. Appendix C. Interpretative Guidelines for In Vitro Susceptibility Testing of Candida Species. Quality Control Mini-mal Inhibitoy Concentration (MIC) Limits for Broth Microdilution and MIC Interpretative Breakpoints (document M27-S2). Wayne, Pennsylvania, 2006.
- AB Biodisk. Etest® Application Sheet — Yeast. EAS 006, 2004.
- Clancy CJ, Nguyen MH. Correlation between in vitro sus-ceptibility determined by E Test and Response to Therapy with Amphotericin B: results from a multicenter perspective study of candidemia. Antimicrob Agents Chemother 1999; 43: 1289–1290.
- Bossche HV. Mechanisms of antifungal resistance. Rev lberoam Micol 1997; 14: 44–49.
- Chryssanthou E, Cuenca M. Comparison of the Antifun-gal Susceptibility Testing Subcommittee of the European Com-mittee on Antibiotic Susceptibility Testing Proposed Standard and the E-Test with the NCCLS Broth Microdilution Method for Voriconazole and Caspofungin Susceptibility Testing of Yeast Species. J Clin Microbiol 2002; 40: 3841–3844.
- Lopes V, Pereira JM, Amorim JM. In vitro activity of six antifungal agents against clinical Candida isolates. Poster Hos-pital de Santo Antonio, Porto, 2007.